International Flavors and Fragrances, Inc. (IFF)

MATERIALS: CHEMICALS
SIC: INDUSTRIAL ORGANIC CHEMICALS

521 W 57TH ST NEW YORK, NY 10019

IFF uses Uncommon Sense to create what the world needs. As a collective of unconventional thinkers and creators, the Company puts science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products its world craves.

Data as of 2021-03-06 09:47:11 -0500
Market Cap33.26 Billion Shares Outstanding248.726 Million Avg 30-day Volume4.011 Million
P/E Ratio91.11466 Dividend Yield2.251 EPS3.21
Price/Sales6.63 Debt to Equity2.15 EBITDA780.17 Million
Price to Book Value5.34 Forward PE23.07 Enterprise Value37.472 Billion
Total Cash649.541 Million Current Debt1.904 Billion Gross Profit2.086 Billion
BETA0.97362 52-week High/Low141.52 / 89.69 Next Earnings Date2021-02-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from IFF instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 3 66.67% 4 (0.24%) 0 (0.0%)
Funds Holding: 562 522 7.66% 110 (6.61%) 99 (6.16%) 11.11%
13F shares: 114.401 Million 101.346 Million 12.88% 19.954 Million 13.812 Million 44.46%
% Ownership 94.7748 18.6591 12.9168 44.46%
New Positions: 104 44 136.36% 29 10 190.0%
Increased Positions 214 163 31.29% 38 29 31.03%
Closed Positions 58 58 0.0% 18 16 12.5%
Reduced Positions 171 217 -21.2% 29 45 -35.56%
Total Calls 3.21 Million 1.205 Million 166.47% 1.412 Million 503.6 Thousand 180.34%
Total Puts 5.168 Million 2.226 Million 132.13% 1.636 Million 985.8 Thousand 65.93%
PUT/CALL Ratio 1.61 1.85 -12.97% 1.16 1.96 -40.82%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IFF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IFF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

11.5 Thousand total shares from 11 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GORDON ILENE S

  • Director
255 2021-03-01 2

BREEN EDWARD D

  • Director
455 2021-03-01 2

DAVIDSON CAROL ANTHONY

  • Director
255 2021-03-01 2

SCHULTZ KARE

  • Director
255 2021-03-01 2

BOOR KATHRYN JEAN

  • Director
255 2021-03-01 2

HEINZEL MATTHIAS

  • Director
255 2021-03-01 2

FIBIG ANDREAS CEO

  • Officer
  • Director
125,674 2021-02-26 27

ANDERSON ROBERT G. CONTROLLER

  • Officer
19,381 2021-02-26 27

JILLA RUSTOM CFO

  • Officer
3,965 2021-02-26 21

JOHNSON JENNIFER AMY EVP, GENERAL COUNSEL

  • Officer
2,466 2021-02-19 6

STRZELECKI ANGELA PRESIDENT, PHARMA SOLUTIONS

  • Officer
2,226 2021-02-19 6

HERRIOTT SIMON PRESIDENT HEALTH & BIOSCIENCES

  • Officer
2,606 2021-02-19 6

DUCKER MICHAEL L

  • Director
7,668 2021-02-10 3

CHWAT ANNE EVP, GC, & CORP. SEC'Y

  • Officer
47,850 2021-01-29 26

HAENI MATTHIAS DIVISIONAL CEO, TASTE

  • Officer
43,330 2020-12-31 4

O'LEARY RICHARD EVP & INTEGRATION OFFICER

  • Officer
26,328 2020-11-30 21

HUDSON KATHERINE M

  • Director
2,500 2020-11-02 3

MORRISON DALE F

  • Director
4,010 2020-11-02 3

EPSTEIN DAVID R

  • Director
0 2020-11-02 3

WILLIAMSON STEPHEN

  • Director
0 2020-11-02 3

FORTMANN KATHY LYNN DIVISIONAL CEO, TASTE

  • Officer
0 2020-10-01 1

FORTANET FRANCISCO EVP, OPERATIONS

  • Officer
21,412 2020-05-06 3

MIRZAYANTZ NICOLAS GROUP PRESIDENT FRAGRANCE

  • Officer
32,452 2020-05-06 4

BOTTOLI MARCELLO

  • Director
3,165 2020-05-06 2

FERGUSON ROGER W. JR.

  • Director
0 2020-05-06 2

GOLD CHRISTINA A

  • Director
5,788 2020-05-06 2

FERRARO JOHN FRANCIS

  • Director
0 2020-05-06 2

YEP GREGORY L EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
3,836 2020-05-06 3

SUAREZ GONZALEZ SUSANA EVP, CHIEF HR OFFICER

  • Officer
5,766 2020-05-06 3

TSAI LI-HUEI

  • Director
591 2020-05-06 2

BUCK LINDA B

  • Director
0 2020-05-01 1

WINDER INVESTMENT PTE LTD

HALDOR FOUNDATION

FREEMONT CAPITAL PTE LTD

  • 10% Owner
24,130,000 2020-03-30 13

PRAST PETER

WALCH ERNST

  • 10% Owner
0 2020-03-12 1

ANATOT AMOS EVP AND PRESIDENT, FRUTAROM

  • Officer
6,502 2019-05-01 0

WINDER INVESTMENT PTE LTD

  • 10% Owner
20,300,000 2019-02-21 13

HOWELL HENRY W JR

  • Director
1,755 2018-01-11 0

LEXMOND WILLIAM CORNELIUS

YAM KWAI YING SHARON

  • 10% Owner
0 2017-03-02 0

HALDOR FOUNDATION

FREEMONT CAPITAL PTE LTD

  • 10% Owner
20,300,000 2017-03-02 0

CANTLON ANGELICA T. EVP, CHIEF HUMAN RESOURCES

  • Officer
0 2016-05-02 0

CORNELL ALISON A EVP & CFO

  • Officer
5,422 2016-05-02 0

BAYDAR AHMET EVP, RESEARCH & DEVELOPMENT

  • Officer
25,347 2016-03-31 0

COOK J MICHAEL

  • Director
6,117 2015-05-01 0

MARTINEZ ARTHUR C

  • Director
2,405 2015-05-01 0

HERZAN ALEXANDRA A

  • Director
5,091 2015-05-01 0

BERRYMAN KEVIN C EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2014-12-15 0

TOUGH DOUGLAS D. CHAIRMAN OF THE BOARD

  • Officer
  • Director
222,785 2014-12-01 0

VAISMAN HERNAN GROUP PRESIDENT, FLAVORS

  • Officer
0 2014-03-27 0

ADAME MARGARET HAYES

  • Director
21,688 2012-05-01 0

FORD BETH EVP, SUPPLY CHAIN

  • Officer
0 2011-12-22 0

GEORGESCU PETER A

  • Director
No longer subject to file 2011-05-03 0

MEANY DENNIS M SVP, GEN.COUNSEL & SEC'Y

  • Officer
No longer subject to file 2010-12-31 0

TANSKY BURTON M

  • Director
8,143 2010-04-27 0

AMEN ROBERT M CHAIRMAN & CEO

  • Officer
  • Director
No longer subject to file 2009-09-30 0

HEASLIP STEVEN J SENIOR VP HUMAN RESOURCES

  • Officer
0 2009-06-30 0

HENDRICKS KIMBERLY A. CONTROLLER

  • Officer
No longer subject to file 2009-06-30 0

BLOBEL GUNTER MD PHD

  • Director
No longer subject to file 2009-04-28 0

FARANDA JOSEPH CHIEF MARKETING OFFICER

  • Officer
15,044 2009-02-16 0

WETMORE DOUGLAS J SENIOR VP, CFO AND TREASURER

  • Officer
0 2008-08-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BOOR KATHRYN JEAN - Director

2021-03-03 17:08:39 -0500 2021-03-01 A 255 a 255 direct

BREEN EDWARD D - Director

2021-03-03 17:08:18 -0500 2021-03-01 A 255 a 255 direct

GORDON ILENE S - Director

2021-03-03 17:08:30 -0500 2021-03-01 A 255 a 255 direct

HEINZEL MATTHIAS - Director

2021-03-03 17:08:47 -0500 2021-03-01 A 255 a 255 direct

DAVIDSON CAROL ANTHONY - Director

2021-03-03 17:08:35 -0500 2021-03-01 A 255 a 255 direct

SCHULTZ KARE - Director

2021-03-03 17:09:00 -0500 2021-03-01 A 255 a 255 direct

JILLA RUSTOM - Officer CFO

2021-03-02 17:12:19 -0500 2021-02-26 A 18 $135.51 a 417 direct

ANDERSON ROBERT G. - Officer CONTROLLER

2021-03-02 17:11:57 -0500 2021-02-26 A 10 $135.51 a 5,354 direct

FIBIG ANDREAS - Director - Officer CEO

2021-03-02 17:12:09 -0500 2021-02-26 A 50 $135.51 a 60,060 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-23 17:34:32 -0500 2021-02-19 M 708 a 961 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-23 17:34:36 -0500 2021-02-19 M 584 a 883 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-23 17:34:22 -0500 2021-02-19 M 616 a 1,038 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-23 17:34:32 -0500 2021-02-19 M 708 d 1,782 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-23 17:34:36 -0500 2021-02-19 M 584 d 1,535 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-23 17:34:22 -0500 2021-02-19 M 616 d 1,758 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-23 17:34:32 -0500 2021-02-19 F 277 $139.24 d 684 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-23 17:34:36 -0500 2021-02-19 F 192 $139.24 d 691 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-23 17:34:22 -0500 2021-02-19 F 190 $139.24 d 848 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-17 21:14:34 -0500 2021-02-15 F 24 $136.21 d 253 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-17 21:14:38 -0500 2021-02-15 F 27 $136.21 d 299 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-17 21:14:46 -0500 2021-02-15 F 35 $136.21 d 422 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-17 21:14:34 -0500 2021-02-15 M 58 d 0 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-17 21:14:34 -0500 2021-02-15 M 58 a 277 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-17 21:14:38 -0500 2021-02-15 M 81 d 0 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-17 21:14:38 -0500 2021-02-15 M 81 a 326 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-17 21:14:46 -0500 2021-02-15 M 105 d 0 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-17 21:14:46 -0500 2021-02-15 M 105 a 457 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-17 21:14:34 -0500 2021-02-14 M 365 d 7,469 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-17 21:14:34 -0500 2021-02-14 F 146 $136.21 d 219 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-17 21:14:38 -0500 2021-02-14 M 365 d 6,356 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-17 21:14:38 -0500 2021-02-14 F 120 $136.21 d 245 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-17 21:14:46 -0500 2021-02-14 M 525 d 7,122 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-19 19:00:00 -0500 2021-02-14 M 365 d 2,119 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-17 21:14:46 -0500 2021-02-14 F 173 $136.21 d 352 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-17 21:14:34 -0500 2021-02-14 M 365 a 365 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-17 21:14:38 -0500 2021-02-14 M 365 a 365 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-19 18:59:54 -0500 2021-02-14 M 525 d 2,374 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-17 21:14:46 -0500 2021-02-14 M 525 a 525 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-19 18:59:55 -0500 2021-02-14 M 365 d 2,490 direct

JILLA RUSTOM - Officer CFO

2021-02-17 21:14:17 -0500 2021-02-12 A 18 $134.06 a 400 direct

FIBIG ANDREAS - Director - Officer CEO

2021-02-17 21:14:29 -0500 2021-02-12 A 51 $134.06 a 60,010 direct

ANDERSON ROBERT G. - Officer CONTROLLER

2021-02-17 21:14:13 -0500 2021-02-12 A 10 $134.06 a 5,343 direct

DUCKER MICHAEL L - Director

2021-02-12 19:21:47 -0500 2021-02-10 M 7,668 a 7,668 direct

DUCKER MICHAEL L - Director

2021-02-12 19:21:47 -0500 2021-02-10 M 7,668 d 0 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-19 18:56:37 -0500 2021-02-01 A 731 a 2,855 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 1,513 a 1,513 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 4,068 a 4,068 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-19 18:56:47 -0500 2021-02-01 A 2,125 a 2,125 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 2,100 a 7,647 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-19 18:56:47 -0500 2021-02-01 A 731 a 2,484 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-03 17:58:53 -0500 2021-02-01 A 6,375 a 6,375 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-03 17:58:53 -0500 2021-02-01 A 81 a 81 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-03 17:59:07 -0500 2021-02-01 A 11,702 a 11,702 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-03 17:59:07 -0500 2021-02-01 A 3,241 a 3,241 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-03 17:59:07 -0500 2021-02-01 A 6,372 a 6,372 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-19 18:56:19 -0500 2021-02-01 A 1,356 a 1,356 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-19 18:56:37 -0500 2021-02-01 A 3,137 a 3,137 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-19 18:56:37 -0500 2021-02-01 A 2,124 a 2,124 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 9,606 a 9,606 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 3,241 a 3,241 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-19 18:56:47 -0500 2021-02-01 A 2,588 a 2,588 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 5,547 a 5,547 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-19 18:56:47 -0500 2021-02-01 A 1,753 a 1,753 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-03 17:58:53 -0500 2021-02-01 A 7,764 a 7,764 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-03 17:58:53 -0500 2021-02-01 A 1,462 a 6,721 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-03 17:59:07 -0500 2021-02-01 A 9,411 a 9,411 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-03 17:59:07 -0500 2021-02-01 A 58 a 58 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-19 18:56:19 -0500 2021-02-01 A 3,202 a 3,202 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-19 18:56:19 -0500 2021-02-01 A 1,050 a 2,899 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-19 18:56:37 -0500 2021-02-01 A 747 a 747 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 11,702 a 11,702 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 8,469 a 8,469 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-19 18:56:47 -0500 2021-02-01 A 3,481 a 3,481 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-03 17:58:31 -0500 2021-02-01 A 105 a 105 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-19 18:56:47 -0500 2021-02-01 A 1,046 a 1,046 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-03 17:58:53 -0500 2021-02-01 A 10,443 a 10,443 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-03 17:58:53 -0500 2021-02-01 A 3,138 a 3,138 direct

STRZELECKI ANGELA - Officer PRESIDENT, PHARMA SOLUTIONS

2021-02-03 17:58:53 -0500 2021-02-01 A 5,259 a 5,259 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-03 17:59:07 -0500 2021-02-01 A 2,241 a 2,241 direct

JOHNSON JENNIFER AMY - Officer EVP, GENERAL COUNSEL

2021-02-03 17:59:07 -0500 2021-02-01 A 1,462 a 7,834 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-19 18:56:19 -0500 2021-02-01 A 2,823 a 2,823 direct

HERRIOTT SIMON - Officer PRESIDENT HEALTH & BIOSCIENCES

2021-02-19 18:56:19 -0500 2021-02-01 A 1,849 a 1,849 direct

JILLA RUSTOM - Officer CFO

2021-02-02 17:44:36 -0500 2021-01-29 A 21 $112.38 a 382 direct

CHWAT ANNE - Officer EVP, GC, & CORP. SEC'Y

2021-02-02 17:44:16 -0500 2021-01-29 A 115 $112.38 a 5,112 direct

ANDERSON ROBERT G. - Officer CONTROLLER

2021-02-02 17:44:03 -0500 2021-01-29 A 11 $112.38 a 5,333 direct

FIBIG ANDREAS - Director - Officer CEO

2021-02-02 17:44:28 -0500 2021-01-29 A 60 $112.38 a 59,959 direct

CHWAT ANNE - Officer EVP, GC, & CORP. SEC'Y

2021-01-20 18:30:47 -0500 2021-01-15 A 110 $117.72 a 4,997 direct

FIBIG ANDREAS - Director - Officer CEO

2021-01-20 18:30:52 -0500 2021-01-15 A 58 $117.72 a 59,899 direct

ANDERSON ROBERT G. - Officer CONTROLLER

2021-01-20 18:30:42 -0500 2021-01-15 A 11 $117.72 a 5,322 direct

JILLA RUSTOM - Officer CFO

2021-01-20 18:30:57 -0500 2021-01-15 A 20 $117.72 a 361 direct

CHWAT ANNE - Officer EVP, GC, & CORP. SEC'Y

2021-01-12 18:19:02 -0500 2021-01-08 M 470 a 43,341 direct -1.3002 -4.5425 11.5154 15.6712 27 -9.7573 10

CHWAT ANNE - Officer EVP, GC, & CORP. SEC'Y

2021-01-12 18:19:02 -0500 2021-01-08 M 470 d 4,887 direct

CHWAT ANNE - Officer EVP, GC, & CORP. SEC'Y

2021-01-12 18:19:02 -0500 2021-01-08 F 169 $107.99 d 43,172 direct -1.3002 -4.5425 11.5154 15.6712 27 -9.7573 10

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 22:15:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 21:45:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 21:15:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 20:45:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 20:15:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 19:45:02 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 19:15:02 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 18:45:02 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 18:15:02 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 17:45:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 17:15:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 16:45:02 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 16:15:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 15:45:02 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 15:15:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 14:45:03 UTC -0.18 0.25 9300000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 14:15:03 UTC -0.18 0.25 9200000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 13:45:03 UTC -0.18 0.25 9200000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 13:15:03 UTC -0.18 0.25 9200000
INTL FLAVORS & FRAGRANCES IFF 2021-03-08 12:45:03 UTC -0.18 0.25 9200000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
PACE SELECT ADVISORS TRUST- PACE Large Co Value Equity Investments IFF -8126.0 shares, $-834215.16 2020-10-31 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund IFF -71000.0 shares, $-7288860.0 2020-10-31 N-PORT
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund IFF -2214.0 shares, $-285650.28 2019-12-31 N-PORT
GLENMEDE FUND INC- Quantitative U.S. Total Market Equity Portfolio IFF -2000.0 shares, $-205320.0 2020-10-31 N-PORT
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund IFF -875.0 shares, $-112892.5 2019-12-31 N-PORT
Dunham Funds- Dunham Monthly Distribution Fund IFF -6489.0 shares, $-666160.74 2020-10-31 N-PORT
JNL Series Trust- JNL/FPA + DoubleLine Flexible Allocation Fund IFF -61315.0 shares, $-6259035.2 2020-03-31 N-PORT
AdvisorShares Trust- AdvisorShares Ranger Equity Bear ETF IFF -12000.0 shares, $-1306080.0 2020-12-31 N-PORT
RBB Fund, Inc.- Boston Partners Long/Short Research Fund IFF -28538.0 shares, $-3199109.8 2020-11-30 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund IFF -204.0 shares, $-22203.36 2020-12-31 N-PORT
SEI INSTITUTIONAL INVESTMENTS TRUST- SIIT MULTI-ASSET REAL RETURN FUND IFF -1618.0 shares, $-181377.8 2020-11-30 N-PORT
Principal Funds, Inc- Global Multi-Strategy Fund IFF 6328.0 shares, $-709368.8 2020-11-30 N-PORT
NEUBERGER BERMAN ALTERNATIVE FUNDS- Neuberger Berman Long Short Fund IFF -80000.0 shares, $-8212800.0 2020-10-31 N-PORT
Neuberger Berman Alternative Funds- Neuberger Berman Absolute Return Multi-Manager Fund IFF -1414.0 shares, $-145161.24 2020-10-31 N-PORT
RBB Fund, Inc.- Boston Partners Global Long/Short Fund IFF -5132.0 shares, $-575297.2 2020-11-30 N-PORT
Professionally Managed Portfolios- Otter Creek Long/Short Opportunity Fund IFF -23304.0 shares, $-2392388.64 2020-10-31 N-PORT
JNL Series Trust- JNL/Boston Partners Global Long Short Equity Fund IFF -1679.0 shares, $-182742.36 2020-12-31 N-PORT
Advanced Series Trust- AST Neuberger Berman Long/Short Portfolio IFF -800.0 shares, $-97968.0 2020-06-30 N-PORT
Series Portfolios Trust- Weiss Alternative Balanced Risk Fund IFF -1225.0 shares, $-125758.5 2020-10-31 N-PORT
Legg Mason Global Asset Management Trust- QS Global Market Neutral Fund IFF -2209.0 shares, $-240427.56 2020-12-31 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund IFF -24.0 shares, $-2612.16 2020-12-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund IFF -2756.0 shares, $-282930.96 2020-10-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund IFF -596.0 shares, $-73123.24 2019-09-30 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund IFF -694.0 shares, $-71246.04 2020-10-30 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund IFF -835.0 shares, $-90881.4 2020-12-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF IFF -3258.0 shares, $-354600.72 2020-12-31 N-PORT
GLENMEDE FUND INC- Alternative Risk Premia Portfolio IFF -113.0 shares, $-14806.39 2020-04-30 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund IFF -1606.0 shares, $-174797.04 2020-12-31 N-PORT
SEI INSTITUTIONAL MANAGED TRUST- SIMT Multi-Asset Inflation Managed Fund IFF -1682.0 shares, $-183068.88 2020-12-31 N-PORT

Short Position History (International Only)

Holder Net Short Position Position Date Origin
TWO SIGMA ADVISERS, LP INTERNATIONAL FLAVORS & 0.5% 2019-06-27 FRANCE
TWO SIGMA ADVISERS, LP INTERNATIONAL FLAVORS & 0.48% 2019-08-13 FRANCE

Elevate your investments